Paul Freer

Title: Innovations in Cardiac Therapy by Paul Freer

Introduction

Paul Freer is an accomplished inventor based in Anaheim, CA, known for his significant contributions to cardiac therapy technologies. With a total of 3 patents, Freer has focused on developing methods and devices that enhance the treatment of cardiac conditions, particularly through subcutaneous systems.

Latest Patents

Freer's latest patents include groundbreaking innovations such as "Low energy conversion of ventricular tachycardia in a subcutaneous defibrillator." This patent outlines methods for delivering anti-tachycardia pacing therapy and low energy cardioversion therapy through a subcutaneous device. The technology ensures synchronization of therapy delivery based on the analysis of subcutaneous signals. Another notable patent is "Implantable cardiac systems with baseline correction in response to noise detection." This invention describes a method for identifying noise events in implantable cardiac devices and initiating a baseline correction algorithm to improve device performance.

Career Highlights

Throughout his career, Paul Freer has worked with prominent companies in the medical device industry, including Cameron Health, Inc. and Cardiac Pacemakers, Inc. His experience in these organizations has allowed him to refine his expertise in cardiac device technology and contribute to advancements in patient care.

Collaborations

Freer has collaborated with notable professionals in the field, including Venugopal Allavatam and Rick Sanghera. These partnerships have fostered innovation and development in cardiac therapy solutions.

Conclusion

Paul Freer's work in cardiac therapy exemplifies the impact of innovative thinking in medical technology. His patents and career achievements highlight his commitment to improving patient outcomes through advanced cardiac devices.